Pharmacists face real challenges when substituting brand-name drugs with generics-patient mistrust, lack of prescriber communication, and time constraints. This article explores their perspectives and what needs to change.
Pharmacokinetic studies are the main way regulators prove generic drugs work like brand-name versions, but they’re not foolproof. Learn how they work, where they fail, and what’s changing in generic drug approval.
Real provider experiences with generic medications reveal that while most generics work just as well as brand-name drugs, careful consideration is needed for narrow therapeutic index medications like warfarin, levothyroxine, and antiepileptics.
